Tango Therapeutics Inc. (TNGX)

NASDAQ: TNGX · Real-Time Price · USD

1.33

-0.03 (-2.21%)

At close: Apr 30, 2025, 1:03 PM

Tango Therapeutics Cash Flow Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Net Income	-130.3M	-101.74M	-108.18M	-58.23M	-51.97M	-14.1M
Depreciation & Amortization	n/a	2.42M	1.61M	897K	718K	643K
Stock-Based Compensation	n/a	19.08M	14.23M	7.83M	1.76M	1.69M
Other Working Capital	-30.56M	-38.26M	-19.59M	-12.58M	119.08M	1.7M
Other Non-Cash Items	-1.2M	234K	1.75M	1.32M	890K	-14.74M
Deferred Income Tax	n/a	n/a	n/a	n/a	n/a	n/a
Change in Working Capital	n/a	-37.97M	-18.49M	-11.35M	118.67M	1.7M
Operating Cash Flow	-131.5M	-117.98M	-109.08M	-59.53M	70.07M	-24.8M
Capital Expenditures	n/a	-1.53M	-7.69M	-1.84M	-1.11M	-1.82M
Cash Acquisitions	n/a	n/a	-34.09M	181.6M	n/a	n/a
Purchase of Investments	n/a	-310.57M	-208.5M	-372.36M	-207.54M	n/a
Sales Maturities Of Investments	n/a	353.53M	242.59M	190.76M	63.22M	n/a
Other Investing Acitivies	86.13M	n/a	34.09M	-181.6M	-40K	2.67M
Investing Cash Flow	86.13M	41.43M	26.4M	-183.43M	-145.47M	848K
Debt Repayment	n/a	n/a	n/a	342.11M	n/a	n/a
Common Stock Repurchased	n/a	n/a	n/a	n/a	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	5.94M	2.39M	1.61M	-14.78M	40K	11M
Financial Cash Flow	47.66M	82.41M	1.61M	357.32M	80.88M	11M
Net Cash Flow	2.29M	5.85M	-81.07M	114.36M	5.49M	25.17M
Free Cash Flow	-131.5M	-119.51M	-116.77M	-61.36M	68.97M	-26.62M